WASHINGTON – Pfizer CEO says “it is a question of days, not weeks” before the company and German partner BioNTech submit data to US regulators for federal authorization of a COVID-19 vaccine for children aged 5 to 11 Do it.
This would be an important step toward introducing vaccinations to young people, especially those with children who are now back in school and the Delta version resulting in a large jump in pediatric infections.
Pfizer said last week that its vaccine works for that age group and that it is testing a very small dose of the vaccine that is already available for people 12 and older. The company said that after children ages 5 to 11 received a second dose during the trial, they had the same levels of coronavirus-fighting antibodies as teenagers and young adults getting the regular-strength shots. .
Pfizer CEO Albert Bourla said Sunday that if the Food and Drug Administration approves the company’s application, “we will be ready with our manufacturing to make this new formulation of the vaccine available.”
And when it comes to the coronavirus pandemic, he said on ABC’s “This Week” that within a year, “I think we’ll be able to get back to normal life. I don’t think that means variants don’t keep coming.” And I don’t think that means we should be able to live our lives … without vaccinations, basically.”
Borla also said that “we will have vaccines that … will last at least a year” and that “the most likely scenario, this is annual revaccination.”
More on the pandemic:
– US has enough COVID-19 vaccines for boosters, shots for kids
UK relies on vaccines, ‘common sense’ to keep virus at bay
— Explainer: Who is eligible for Pfizer booster shots in the US?
All pandemic coverage of AP https://apnews.com/hub/coronavirus-pandemic . look at
Here’s what else is happening:
HELSINKI – Police in Norway have reported dozens of disturbances and violent clashes, including massive brawls in the Nordic country’s large cities, with people celebrating the end of COVID-19 restrictions in the streets, bars, restaurants and nightclubs were filled with
Norway’s government suddenly announced on Friday that most of the remaining coronavirus restrictions would be lifted from Saturday and life would return to normal in the nation of 5.3 million.
The unexpected announcement by Prime Minister Erna Solberg to release coronavirus restrictions late Friday the next day took many in Norway by surprise and led to chaotic scenes in the capital Oslo and elsewhere in the country on Saturday.
Rowdy festivities across Norway by hundreds of citizens began on Saturday afternoon and lasted until the early hours of Sunday. Police said unrest was reported in several places, including the southern city of Bergen and the central city of Trondheim, while the situation was worst in Oslo.
PHOENIX – Health officials in Arizona reported 2,579 more COVID-19 cases and six additional deaths on Sunday.
The latest numbers took the state’s total to 1,804,369 cases and 19,812 known deaths since the pandemic began.
On Saturday, Arizona reported 2,916 additional confirmed COVID-19 cases and 69 more deaths as the pace of virus deaths nearly doubled over the past two weeks.
According to the Arizona Department of Health Services COVID-19 Dashboard, 1,834 COVID-19 patients were in hospital beds as of Friday — a level below the current surge peak of 2,103 on Sept. 12.
More than 4.1 million people (57.7% of the state’s population) have received at least one dose of the vaccine and more than 3.6 million residents have been fully vaccinated (51.1% of the population).
NEW YORK – New York City schools have been temporarily barred from enforcing a vaccine mandate for their teachers and other staff by a federal appeals judge before it takes effect.
The mandate for the country’s largest school system was due to go into effect on Monday.
But late Friday, a judge at the Second US Circuit Court of Appeals granted a temporary injunction and referred the case to a three-judge panel on an expedited basis.
Education Department spokesman Daniel Filson said officials are seeking an early resolution by the circuit court next week.
Credit: www.independent.co.uk / Pfizer